Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study

DOI record: { "DOI": "10.1016/j.semarthrit.2022.152108", "ISSN": [ "0049-0172" ], "URL": "http://dx.doi.org/10.1016/j.semarthrit.2022.152108", "alternative-id": [ "S0049017222001597" ], "article-number": "152108", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study" }, { "label": "Journal Title", "name": "journaltitle", "value": "Seminars in Arthritis and Rheumatism" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.semarthrit.2022.152108" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 Elsevier Inc. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Patel", "given": "Naomi J.", "sequence": "first" }, { "affiliation": [], "family": "Wang", "given": "Xiaosong", "sequence": "additional" }, { "affiliation": [], "family": "Fu", "given": "Xiaoqing", "sequence": "additional" }, { "affiliation": [], "family": "Kawano", "given": "Yumeko", "sequence": "additional" }, { "affiliation": [], "family": "Cook", "given": "Claire", "sequence": "additional" }, { "affiliation": [], "family": "Vanni", "given": "Kathleen M.M.", "sequence": "additional" }, { "affiliation": [], "family": "Qian", "given": "Grace", "sequence": "additional" }, { "affiliation": [], "family": "Banasiak", "given": "Emily", "sequence": "additional" }, { "affiliation": [], "family": "Kowalski", "given": "Emily", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Yuqing", "sequence": "additional" }, { "affiliation": [], "family": "Sparks", "given": "Jeffrey A.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-4708-7038", "affiliation": [], "authenticated-orcid": false, "family": "Wallace", "given": "Zachary S.", "sequence": "additional" } ], "container-title": "Seminars in Arthritis and Rheumatism", "container-title-short": "Seminars in Arthritis and Rheumatism", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.com.au", "clinicalkey.es", "clinicalkey.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 10, 26 ] ], "date-time": "2022-10-26T23:46:53Z", "timestamp": 1666828013000 }, "deposited": { "date-parts": [ [ 2022, 10, 26 ] ], "date-time": "2022-10-26T23:47:13Z", "timestamp": 1666828033000 }, "indexed": { "date-parts": [ [ 2022, 10, 27 ] ], "date-time": "2022-10-27T04:59:46Z", "timestamp": 1666846786484 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 10 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 1 ] ], "date-time": "2022-10-01T00:00:00Z", "timestamp": 1664582400000 } }, { "URL": "https://doi.org/10.15223/policy-017", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 1 ] ], "date-time": "2022-10-01T00:00:00Z", "timestamp": 1664582400000 } }, { "URL": "https://doi.org/10.15223/policy-037", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 1 ] ], "date-time": "2022-10-01T00:00:00Z", "timestamp": 1664582400000 } }, { "URL": "https://doi.org/10.15223/policy-012", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 1 ] ], "date-time": "2022-10-01T00:00:00Z", "timestamp": 1664582400000 } }, { "URL": "https://doi.org/10.15223/policy-029", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 1 ] ], "date-time": "2022-10-01T00:00:00Z", "timestamp": 1664582400000 } }, { "URL": "https://doi.org/10.15223/policy-004", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 1 ] ], "date-time": "2022-10-01T00:00:00Z", "timestamp": 1664582400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0049017222001597?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0049017222001597?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "152108", "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 10 ] ] }, "published-print": { "date-parts": [ [ 2022, 10 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/S2665-9913(22)00096-0", "article-title": "Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis", "author": "Widdifield", "doi-asserted-by": "crossref", "first-page": "e430", "journal-title": "Lancet Rheumatol", "key": "10.1016/j.semarthrit.2022.152108_bib0001", "volume": "4", "year": "2022" }, { "DOI": "10.1136/annrheumdis-2021-221326", "article-title": "Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases", "author": "Cook", "doi-asserted-by": "crossref", "first-page": "289", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0002", "volume": "81", "year": "2022" }, { "DOI": "10.1016/j.coph.2022.102243", "article-title": "Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases", "author": "Paik", "doi-asserted-by": "crossref", "journal-title": "Curr Opin Pharmacol", "key": "10.1016/j.semarthrit.2022.152108_bib0003", "volume": "65", "year": "2022" }, { "DOI": "10.1136/rmdopen-2021-002187", "article-title": "SARS-CoV-2 Breakthrough Infections Among Vaccinated Individuals with Rheumatic Disease: Results From the COVID-19 Global Rheumatology Alliance Provider Registry", "author": "Liew", "doi-asserted-by": "crossref", "journal-title": "RMD Open", "key": "10.1016/j.semarthrit.2022.152108_bib0004", "volume": "8", "year": "2022" }, { "DOI": "10.1016/j.cmi.2021.06.036", "article-title": "BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel", "author": "Brosh-Nissimov", "doi-asserted-by": "crossref", "first-page": "1652", "journal-title": "Clin Microbiol Infect", "key": "10.1016/j.semarthrit.2022.152108_bib0005", "volume": "27", "year": "2021" }, { "DOI": "10.1080/13696998.2021.2002063", "article-title": "Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2", "author": "Di Fusco", "doi-asserted-by": "crossref", "first-page": "1248", "journal-title": "J Med Econ", "key": "10.1016/j.semarthrit.2022.152108_bib0006", "volume": "24", "year": "2021" }, { "DOI": "10.1136/annrheumdis-2020-217888", "article-title": "Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'", "author": "D'Silva", "doi-asserted-by": "crossref", "first-page": "1156", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0007", "volume": "79", "year": "2020" }, { "article-title": "Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic", "author": "Serling-Boyd", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0008", "year": "2020" }, { "DOI": "10.1101/2021.04.05.21254656", "doi-asserted-by": "crossref", "key": "10.1016/j.semarthrit.2022.152108_bib0009", "unstructured": "Deepak P, Kim W, Paley MA, et al. Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2. medRxiv2021:1-41." }, { "DOI": "10.1136/annrheumdis-2021-221244", "article-title": "Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases", "author": "Friedman", "doi-asserted-by": "crossref", "first-page": "1255", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0010", "volume": "80", "year": "2021" }, { "DOI": "10.1136/annrheumdis-2021-220597", "article-title": "Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease", "author": "Haberman", "doi-asserted-by": "crossref", "first-page": "1339", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0011", "volume": "80", "year": "2021" }, { "DOI": "10.1002/art.41914", "article-title": "Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion", "author": "Simon", "doi-asserted-by": "crossref", "first-page": "33", "journal-title": "Arthritis Rheumatol", "key": "10.1016/j.semarthrit.2022.152108_bib0012", "volume": "74", "year": "2022" }, { "article-title": "Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study", "author": "Furer", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0013", "year": "2021" }, { "DOI": "10.1136/annrheumdis-2021-221217", "article-title": "SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases", "author": "Lawson-Tovey", "doi-asserted-by": "crossref", "first-page": "145", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0014", "volume": "81", "year": "2022" }, { "DOI": "10.1093/rheumatology/keac241", "article-title": "COVID-19 infection and hospitalisation risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis", "author": "Cordtz", "doi-asserted-by": "crossref", "journal-title": "Rheumatology (Oxford)", "key": "10.1016/j.semarthrit.2022.152108_bib0015", "year": "2022" }, { "DOI": "10.1016/S2665-9913(22)00102-3", "article-title": "Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies", "author": "Boekel", "doi-asserted-by": "crossref", "first-page": "e417", "journal-title": "Lancet Rheumatol", "key": "10.1016/j.semarthrit.2022.152108_bib0016", "volume": "4", "year": "2022" }, { "DOI": "10.1001/jamainternmed.2021.7024", "article-title": "Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US", "author": "Sun", "doi-asserted-by": "crossref", "first-page": "153", "journal-title": "JAMA Intern Med", "key": "10.1016/j.semarthrit.2022.152108_bib0017", "volume": "182", "year": "2022" }, { "key": "10.1016/j.semarthrit.2022.152108_bib0018", "unstructured": "COVID-19 Vaccines for People who are Moderately or Severely Immunocompromised. (Accessed July 5, 2022, at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html#:∼:text=For%20people%20who%20are%20immunocompromised,may%20have%20decreased%20over%20time.)" }, { "key": "10.1016/j.semarthrit.2022.152108_bib0019", "unstructured": "Massachusetts Immunization Information System (MIIS). (Accessed July 5, 2022, at https://www.mass.gov/massachusetts-immunization-information-system-miis.)" }, { "key": "10.1016/j.semarthrit.2022.152108_bib0020", "unstructured": "Latest Data on COVID-19 Vaccinations by Race/Ethnicity. (Accessed July 5, 2022, at https://www.kff.org/coronavirus-covid-19/issue-brief/latest-data-on-covid-19-vaccinations-by-race-ethnicity/.)" }, { "DOI": "10.1186/ar3260", "article-title": "Validation of rheumatoid arthritis diagnoses in health care utilization data", "author": "Kim", "doi-asserted-by": "crossref", "first-page": "R32", "journal-title": "Arthritis Res Ther", "key": "10.1016/j.semarthrit.2022.152108_bib0021", "volume": "13", "year": "2011" }, { "article-title": "Calculating the Benefits of a Research Patient Data Repository", "author": "Nalichowski", "first-page": "1044", "journal-title": "AMIA Annu Symp Proc", "key": "10.1016/j.semarthrit.2022.152108_bib0022", "year": "2006" }, { "DOI": "10.1016/0021-9681(87)90171-8", "article-title": "A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation", "author": "Charlson", "doi-asserted-by": "crossref", "first-page": "373", "journal-title": "J Chron Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0023", "volume": "40", "year": "1987" }, { "key": "10.1016/j.semarthrit.2022.152108_bib0024", "unstructured": "Tracking the Omicron variant in Massachusetts. (Accessed July 5, 2022, at https://www.broadinstitute.org/news/tracking-omicron-variant-massachusetts.)" }, { "journal-title": "Centers for Disease Control and Prevention", "key": "10.1016/j.semarthrit.2022.152108_bib0025", "year": "2022" }, { "DOI": "10.1136/rmdopen-2022-002279", "article-title": "Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases", "author": "Fragoulis", "doi-asserted-by": "crossref", "journal-title": "RMD Open", "key": "10.1016/j.semarthrit.2022.152108_bib0026", "volume": "8", "year": "2022" }, { "DOI": "10.1136/annrheumdis-2021-220781", "article-title": "SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity", "author": "Mrak", "doi-asserted-by": "crossref", "first-page": "1345", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0027", "volume": "80", "year": "2021" }, { "DOI": "10.1038/s41591-021-01507-2", "article-title": "Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy", "author": "Apostolidis", "doi-asserted-by": "crossref", "first-page": "1990", "journal-title": "Nat Med", "key": "10.1016/j.semarthrit.2022.152108_bib0028", "volume": "27", "year": "2021" }, { "DOI": "10.1016/S2665-9913(22)00216-8", "article-title": "COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study", "author": "Risk", "doi-asserted-by": "crossref", "journal-title": "The Lancet Rheumatology", "key": "10.1016/j.semarthrit.2022.152108_bib0029", "year": "2022" }, { "article-title": "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry", "author": "Sparks", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0030", "year": "2021" }, { "DOI": "10.1016/S2665-9913(21)00059-X", "article-title": "COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study", "author": "Avouac", "doi-asserted-by": "crossref", "first-page": "e419", "journal-title": "Lancet Rheumatol", "key": "10.1016/j.semarthrit.2022.152108_bib0031", "volume": "3", "year": "2021" }, { "DOI": "10.1136/annrheumdis-2021-221922", "article-title": "Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort", "author": "Ahmed", "doi-asserted-by": "crossref", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.semarthrit.2022.152108_bib0032", "year": "2022" }, { "DOI": "10.1038/s41584-022-00755-x", "article-title": "COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations", "author": "Grainger", "doi-asserted-by": "crossref", "first-page": "191", "journal-title": "Nat Rev Rheumatol", "key": "10.1016/j.semarthrit.2022.152108_bib0033", "volume": "18", "year": "2022" }, { "DOI": "10.1056/NEJMoa2115463", "article-title": "Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans", "author": "Dickerman", "doi-asserted-by": "crossref", "first-page": "105", "journal-title": "N Engl J Med", "key": "10.1016/j.semarthrit.2022.152108_bib0034", "volume": "386", "year": "2022" }, { "DOI": "10.15585/mmwr.mm7049a2", "article-title": "Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021", "author": "Bajema", "doi-asserted-by": "crossref", "first-page": "1700", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "10.1016/j.semarthrit.2022.152108_bib0035", "volume": "70", "year": "2021" } ], "reference-count": 35, "references-count": 35, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0049017222001597" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Anesthesiology and Pain Medicine", "Rheumatology" ], "subtitle": [], "title": "Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy" }